A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

Clinical trial NCT04959981 · COMPLETED

Trial details

NCT number: NCT04959981
Sponsor: Erasca, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-squamous Non-small-cell Lung Cancer

Start date: 2021-09-02
Primary completion: 2023-04-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.